PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
Hosted on MSN11d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
cbc.ca on MSN9d
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health helpKetamine-assisted therapy lifted me out of depression. But it remains costly — and controversial Health Canada approved a ...
Inquirer on MSN7d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
The ‘Black, Black History Month’ Pop-Up Museum sits in Old Town one of the earliest Black communities in Portland, using art, history, and music to celebrate the past and present and set a ...
Verywell Health on MSN14d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback